======= NUDT5 ======= == Gene Information == * **Official Symbol**: NUDT5 * **Official Name**: nudix hydrolase 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=11164|11164]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UKK9|Q9UKK9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NUDT5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NUDT5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609230|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Enzyme that can either act as an ADP-sugar pyrophosphatase in absence of diphosphate or catalyze the synthesis of ATP in presence of diphosphate (PubMed:27257257). In absence of diphosphate, hydrolyzes with similar activities various modified nucleoside diphosphates such as ADP-ribose, ADP-mannose, ADP-glucose, 8-oxo-GDP and 8-oxo-dGDP (PubMed:10567213, PubMed:10722730, PubMed:19699693, PubMed:21389046, PubMed:17052728). Can also hydrolyze other nucleotide sugars with low activity (PubMed:19699693, PubMed:21389046). In presence of diphosphate, mediates the synthesis of ATP in the nucleus by catalyzing the conversion of ADP-ribose to ATP and ribose 5- phosphate. Nuclear ATP synthesis takes place when dephosphorylated at Thr-45 (PubMed:27257257). Nuclear ATP generation is required for extensive chromatin remodeling events that are energy- consuming (PubMed:27257257). Does not play a role in U8 snoRNA decapping activity (By similarity). Binds U8 snoRNA (By similarity). {ECO:0000250|UniProtKB:Q9JKX6, ECO:0000269|PubMed:10567213, ECO:0000269|PubMed:10722730, ECO:0000269|PubMed:17052728, ECO:0000269|PubMed:19699693, ECO:0000269|PubMed:21389046, ECO:0000269|PubMed:27257257}. |NUDIX| |ADP-sugar diphosphatase activity| |8-oxo-dGDP phosphatase activity| |D-ribose catabolic process| |D-ribose metabolic process| |ATP generation from poly-ADP-D-ribose| |pentose catabolic process| |ribonucleoside diphosphate catabolic process| |ADP-ribose diphosphatase activity| |nucleoside diphosphate catabolic process| |m7G(5)pppN diphosphatase activity| |nucleotidyltransferase activity| |pentose metabolic process| |snoRNA binding| |nucleobase-containing small molecule catabolic process| |monosaccharide catabolic process| |ribonucleoside diphosphate metabolic process| |nucleoside phosphate catabolic process| |nucleoside diphosphate metabolic process| |nucleobase-containing small molecule biosynthetic process| |carbohydrate catabolic process| |organophosphate catabolic process| |chromatin remodeling| |monosaccharide metabolic process| |ATP metabolic process| |magnesium ion binding| |ribose phosphate metabolic process| |nucleobase-containing compound catabolic process| |heterocycle catabolic process| |cellular nitrogen compound catabolic process| |small molecule catabolic process| |aromatic compound catabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |carbohydrate metabolic process| |organic cyclic compound catabolic process| |nucleobase-containing small molecule metabolic process| |small molecule biosynthetic process| |chromatin organization| |protein homodimerization activity| |organophosphate metabolic process| |carbohydrate derivative metabolic process| |chromosome organization| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp13|Chloramphenicol 20μM R00 exp13]]|-2.91| |[[:results:exp32|Rifampicin 10μM R00 exp32]]|-2.7| |[[:results:exp423|Zebularine 20μM R07 exp423]]|-2.54| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|-2.5| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|-2.49| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-2.41| |[[:results:exp248|UM0131023 0.05μM R05 exp248]]|-2.41| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-2.3| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|-2.3| |[[:results:exp5|Alpha-Amanitin 0.5μM R00 exp5]]|-2.18| |[[:results:exp243|S-trityl-L-cysteine 0.5μM R05 exp243]]|-2.14| |[[:results:exp191|Hypoxia 5%O2 R04 exp191]]|-2.12| |[[:results:exp12|Chloramphenicol 2μM R00 exp12]]|-2.12| |[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|-2.08| |[[:results:exp224|CB-839 10μM R05 exp224]]|-2.08| |[[:results:exp16|DABN 2μM R00 exp16]]|-2.08| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|-2.06| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.95| |[[:results:exp220|BAY-598 4μM R05 exp220]]|-1.94| |[[:results:exp274|Citral 50μM R06 exp274]]|-1.94| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.91| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|-1.88| |[[:results:exp504|MK2206 4μM R08 exp504]]|-1.86| |[[:results:exp293|Myriocin 25μM R06 exp293]]|-1.84| |[[:results:exp65|Mubritinib 0.2μM R02 exp65]]|-1.8| |[[:results:exp51|Nifuroxazide 1μM R01 exp51]]|-1.78| |[[:results:exp69|Deguelin 0.05μM R02 exp69]]|-1.76| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|-1.75| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|-1.74| |[[:results:exp31|Rifampicin 1μM R00 exp31]]|-1.74| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|-1.73| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.72| |[[:results:exp116|AICAR 240μM R03 exp116]]|1.7| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|1.7| |[[:results:exp332|Adefovir 20μM R07 exp332]]|1.72| |[[:results:exp513|ONC212 0.15μM R08 exp513]]|1.77| |[[:results:exp505|ML-792 0.2μM R08 exp505]]|2| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|2.05| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|2.48| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|2.58| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|2.58| |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|2.78| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.85| |[[:results:exp189|Temozolomide 200μM R04 exp189]]|2.93| |[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|3.36| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|8.08| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9226 * **Expression level (log2 read counts)**: 6.62 {{:chemogenomics:nalm6 dist.png?nolink |}}